A naukri.com initiative
Eu-Startups
2w
169
Berlin-based Aignostics secures €31.4 million Series B to enhance precision medicine with AI
- Berlin-based AI company Aignostics raises €31.4 million in Series B financing.
- Funds will be used to develop new products, fuel growth in the US, and collaborate with Mayo Clinic.
- Investors include ATHOS, Mayo Clinic, HTGF, Wellington Partners, and more.
- Aignostics aims to enhance precision medicine through advanced AI models and computational pathology.
Read Full Article
10 Likes
For uninterrupted reading, download the app